Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Apr;54(2):336-338.
doi: 10.1016/j.jmii.2020.06.011. Epub 2020 Jun 30.

Co-infection of influenza B virus and SARS-CoV-2: A case report from Taiwan

Bo-Ruei Huang  1 , Ya-Lan Lin  2 , Chih-Kang Wan  3 , Jiin-Torng Wu  1 , Chih-Yu Hsu  1 , Ming-Huang Chiu  1 , Cheng-Hua Huang  4
Affiliations
Case Reports

Co-infection of influenza B virus and SARS-CoV-2: A case report from Taiwan

Bo-Ruei Huang et al. J Microbiol Immunol Infect. 2021 Apr.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declarations of Competing Interest No conflict of interest needs to be declared.

Figures

Figure 1
Figure 1
(A) Chest radiograph upon admission, (B) Chest radiograph on day 6, increased infiltrations at bilateral lung. (C) Chest radiograph on day 9, improvement of left lung infiltrations. (D) Chest radiograph on day 15, resolution of bilateral lung infiltrations.
See this image and copyright information in PMC

References

    1. Ding Q., Lu P., Fan Y., Xia Y., Liu M. The clinical characteristics of pneumonia patients co-infected with 2019 novel coronavirus and influenza virus in Wuhan, China. J Med Virol. 2020 doi: 10.1002/jmv.25781. - DOI - PMC - PubMed
    1. Xiaojing W., Ying C., Xu H., Xin Y., Li Z., Fan W. Co-infection with SARS-CoV-2 and influenza A virus in patient with pneumonia, China. Emerg Infect Dis. 2020;26 doi: 10.3201/eid2606.200299. - DOI - PMC - PubMed
    1. Interim guidelines for clinical management of SARS-CoV-2 infection (5th ed.) https://www.cdc.gov.tw/File/Get/-ewtg9-RCAetCPKR4_rnCw Available at.
    1. Lai C.C., Wang C.Y., Hsueh P.R. Co-infections among patients with COVID-19: the need for combination therapy with non-anti-SARS-CoV-2 agents? J Microbiol Immunol Infect. 2020 doi: 10.1016/j.jmii.2020.05.013. - DOI - PMC - PubMed
    1. Gautret P., Lagier J.C., Parola P., Hoang V.T., Meddeb L., Mailhe M. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020:105949. doi: 10.1016/j.ijantimicag.2020.105949. - DOI - PMC - PubMed